Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease

Eloise Hudry, Hai Yan Wu, Michal Arbel-Ornath, Tadafumi Hashimoto, Roland Matsouaka, Zhanyun Fan, Tara L. Spires-Jones, Rebecca Betensky, Brian J. Bacskai, Bradley T. Hyman

Research output: Contribution to journalArticle

Abstract

Amyloid β (Aβ) peptides, the main pathological species associated with Alzheimer's disease (AD), disturb intracellular calcium homeostasis, which in turn activates the calcium-dependent phosphatase calcineurin (CaN). CaN activation induced by Aβ leads to pathological morphological changes in neurons, and overexpression of constitutively active calcineurin is sufficient to generate a similar phenotype, even without Aβ. Here, we tested the hypothesis that calcineurin mediates neurodegenerative effects via activation of the nuclear transcription factor of activated T-cells (NFAT). We found that both spine loss and dendritic branching simplification induced by Aβ exposure were mimicked by constitutively active NFAT, and abolished when NFAT activation was blocked using the genetically encoded inhibitor VIVIT. When VIVIT was specifically addressed to the nucleus, identical beneficial effects were observed, thus enforcing the role of NFAT transcriptional activity in Aβ-related neurotoxicity. In vivo, when VIVIT or its nuclear counterpart were overexpressed in a transgenic model of Alzheimer's disease via a gene therapy approach, the spine loss and neuritic abnormalities observed in the vicinity of amyloid plaques were blocked. Overall, these results suggest that NFAT/calcineurin transcriptional cascades contribute to Aβ synaptotoxicity, and may provide a new specific set of pathways for neuroprotective strategies.

Original languageEnglish (US)
Pages (from-to)3176-3192
Number of pages17
JournalJournal of Neuroscience
Volume32
Issue number9
DOIs
StatePublished - Feb 29 2012

Fingerprint

NFATC Transcription Factors
Amyloid
Calcineurin
Alzheimer Disease
Transcription Factors
Calcium
Dendritic Spines
Amyloid Plaques
Genetic Therapy
Spine
Homeostasis
Inhibition (Psychology)
Phenotype
Neurons
Peptides

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Hudry, E., Wu, H. Y., Arbel-Ornath, M., Hashimoto, T., Matsouaka, R., Fan, Z., ... Hyman, B. T. (2012). Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease. Journal of Neuroscience, 32(9), 3176-3192. https://doi.org/10.1523/JNEUROSCI.6439-11.2012

Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease. / Hudry, Eloise; Wu, Hai Yan; Arbel-Ornath, Michal; Hashimoto, Tadafumi; Matsouaka, Roland; Fan, Zhanyun; Spires-Jones, Tara L.; Betensky, Rebecca; Bacskai, Brian J.; Hyman, Bradley T.

In: Journal of Neuroscience, Vol. 32, No. 9, 29.02.2012, p. 3176-3192.

Research output: Contribution to journalArticle

Hudry, E, Wu, HY, Arbel-Ornath, M, Hashimoto, T, Matsouaka, R, Fan, Z, Spires-Jones, TL, Betensky, R, Bacskai, BJ & Hyman, BT 2012, 'Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease', Journal of Neuroscience, vol. 32, no. 9, pp. 3176-3192. https://doi.org/10.1523/JNEUROSCI.6439-11.2012
Hudry, Eloise ; Wu, Hai Yan ; Arbel-Ornath, Michal ; Hashimoto, Tadafumi ; Matsouaka, Roland ; Fan, Zhanyun ; Spires-Jones, Tara L. ; Betensky, Rebecca ; Bacskai, Brian J. ; Hyman, Bradley T. / Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease. In: Journal of Neuroscience. 2012 ; Vol. 32, No. 9. pp. 3176-3192.
@article{eb365fa6ccee43699007be435630ac85,
title = "Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease",
abstract = "Amyloid β (Aβ) peptides, the main pathological species associated with Alzheimer's disease (AD), disturb intracellular calcium homeostasis, which in turn activates the calcium-dependent phosphatase calcineurin (CaN). CaN activation induced by Aβ leads to pathological morphological changes in neurons, and overexpression of constitutively active calcineurin is sufficient to generate a similar phenotype, even without Aβ. Here, we tested the hypothesis that calcineurin mediates neurodegenerative effects via activation of the nuclear transcription factor of activated T-cells (NFAT). We found that both spine loss and dendritic branching simplification induced by Aβ exposure were mimicked by constitutively active NFAT, and abolished when NFAT activation was blocked using the genetically encoded inhibitor VIVIT. When VIVIT was specifically addressed to the nucleus, identical beneficial effects were observed, thus enforcing the role of NFAT transcriptional activity in Aβ-related neurotoxicity. In vivo, when VIVIT or its nuclear counterpart were overexpressed in a transgenic model of Alzheimer's disease via a gene therapy approach, the spine loss and neuritic abnormalities observed in the vicinity of amyloid plaques were blocked. Overall, these results suggest that NFAT/calcineurin transcriptional cascades contribute to Aβ synaptotoxicity, and may provide a new specific set of pathways for neuroprotective strategies.",
author = "Eloise Hudry and Wu, {Hai Yan} and Michal Arbel-Ornath and Tadafumi Hashimoto and Roland Matsouaka and Zhanyun Fan and Spires-Jones, {Tara L.} and Rebecca Betensky and Bacskai, {Brian J.} and Hyman, {Bradley T.}",
year = "2012",
month = "2",
day = "29",
doi = "10.1523/JNEUROSCI.6439-11.2012",
language = "English (US)",
volume = "32",
pages = "3176--3192",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "9",

}

TY - JOUR

T1 - Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease

AU - Hudry, Eloise

AU - Wu, Hai Yan

AU - Arbel-Ornath, Michal

AU - Hashimoto, Tadafumi

AU - Matsouaka, Roland

AU - Fan, Zhanyun

AU - Spires-Jones, Tara L.

AU - Betensky, Rebecca

AU - Bacskai, Brian J.

AU - Hyman, Bradley T.

PY - 2012/2/29

Y1 - 2012/2/29

N2 - Amyloid β (Aβ) peptides, the main pathological species associated with Alzheimer's disease (AD), disturb intracellular calcium homeostasis, which in turn activates the calcium-dependent phosphatase calcineurin (CaN). CaN activation induced by Aβ leads to pathological morphological changes in neurons, and overexpression of constitutively active calcineurin is sufficient to generate a similar phenotype, even without Aβ. Here, we tested the hypothesis that calcineurin mediates neurodegenerative effects via activation of the nuclear transcription factor of activated T-cells (NFAT). We found that both spine loss and dendritic branching simplification induced by Aβ exposure were mimicked by constitutively active NFAT, and abolished when NFAT activation was blocked using the genetically encoded inhibitor VIVIT. When VIVIT was specifically addressed to the nucleus, identical beneficial effects were observed, thus enforcing the role of NFAT transcriptional activity in Aβ-related neurotoxicity. In vivo, when VIVIT or its nuclear counterpart were overexpressed in a transgenic model of Alzheimer's disease via a gene therapy approach, the spine loss and neuritic abnormalities observed in the vicinity of amyloid plaques were blocked. Overall, these results suggest that NFAT/calcineurin transcriptional cascades contribute to Aβ synaptotoxicity, and may provide a new specific set of pathways for neuroprotective strategies.

AB - Amyloid β (Aβ) peptides, the main pathological species associated with Alzheimer's disease (AD), disturb intracellular calcium homeostasis, which in turn activates the calcium-dependent phosphatase calcineurin (CaN). CaN activation induced by Aβ leads to pathological morphological changes in neurons, and overexpression of constitutively active calcineurin is sufficient to generate a similar phenotype, even without Aβ. Here, we tested the hypothesis that calcineurin mediates neurodegenerative effects via activation of the nuclear transcription factor of activated T-cells (NFAT). We found that both spine loss and dendritic branching simplification induced by Aβ exposure were mimicked by constitutively active NFAT, and abolished when NFAT activation was blocked using the genetically encoded inhibitor VIVIT. When VIVIT was specifically addressed to the nucleus, identical beneficial effects were observed, thus enforcing the role of NFAT transcriptional activity in Aβ-related neurotoxicity. In vivo, when VIVIT or its nuclear counterpart were overexpressed in a transgenic model of Alzheimer's disease via a gene therapy approach, the spine loss and neuritic abnormalities observed in the vicinity of amyloid plaques were blocked. Overall, these results suggest that NFAT/calcineurin transcriptional cascades contribute to Aβ synaptotoxicity, and may provide a new specific set of pathways for neuroprotective strategies.

UR - http://www.scopus.com/inward/record.url?scp=84863238028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863238028&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.6439-11.2012

DO - 10.1523/JNEUROSCI.6439-11.2012

M3 - Article

C2 - 22378890

AN - SCOPUS:84863238028

VL - 32

SP - 3176

EP - 3192

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 9

ER -